385 related articles for article (PubMed ID: 3104388)
1. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ
J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388
[TBL] [Abstract][Full Text] [Related]
2. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
3. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
4. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
[TBL] [Abstract][Full Text] [Related]
5. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D
J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
[TBL] [Abstract][Full Text] [Related]
6. Compensatory response of the luteinizing-hormone (LH)-releasing hormone (LHRH)/LH pulse generator after administration of a potent LHRH antagonist in the ram.
Lincoln GA; Fraser HM
Endocrinology; 1987 Jun; 120(6):2245-50. PubMed ID: 3032581
[TBL] [Abstract][Full Text] [Related]
7. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
[TBL] [Abstract][Full Text] [Related]
8. Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men.
Pavlou SN; Interlandi JW; Wakefield G; Island DP; Rivier J; Vale W; Kovacs WJ
J Clin Endocrinol Metab; 1987 May; 64(5):1070-4. PubMed ID: 3104387
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys.
Burgos-Briceño LA; Schally AV; Bartke A; Asch RH
J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix).
Marshall LA; Fluker MR; Jaffe RB; Monroe SE
J Clin Endocrinol Metab; 1991 Apr; 72(4):927-33. PubMed ID: 2005220
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pituitary-gonadal function in male rats by a potent GnRH antagonist.
Puente M; Catt KJ
J Steroid Biochem; 1986 Dec; 25(6):917-25. PubMed ID: 3025519
[TBL] [Abstract][Full Text] [Related]
12. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.
Behre HM; Klein B; Steinmeyer E; McGregor GP; Voigt K; Nieschlag E
J Clin Endocrinol Metab; 1992 Aug; 75(2):393-8. PubMed ID: 1639941
[TBL] [Abstract][Full Text] [Related]
13. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
[TBL] [Abstract][Full Text] [Related]
15. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
Erb K; Pechstein B; Schueler A; Engel J; Hermann R
Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648
[TBL] [Abstract][Full Text] [Related]
16. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
Fluker MR; Marshall LA; Monroe SE; Jaffe RB
J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
[TBL] [Abstract][Full Text] [Related]
17. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
18. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
19. Suppression of pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist and antagonist: acute and long-term effects.
Kolho KL; Huhtaniemi I
J Endocrinol; 1989 Oct; 123(1):83-91. PubMed ID: 2509621
[TBL] [Abstract][Full Text] [Related]
20. Recovery of pituitary-gonadal function in male rats after long-term suppression induced by a single injection of microcapsules of LH-RH antagonist cetrorelix (SB-75).
Pinski J; Yano T; Szepeshazi K; Groot K; Schally AV
J Androl; 1993; 14(3):164-9. PubMed ID: 8407570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
